Extrauterine growth restriction is a major clinical problem for prematurely born neonates, especially critically ill preterm neonates, and malnutrition in the neonatal intensive-care unit remains common. There are numerous perceived risks to initiation of adequate nutritional support. How many of these factors pose a real risk to health outcomes is less clear. Current nutritional support does not prevent extrauterine growth restriction and the consequences of malnutrition are both acute and delayed. Our clinical approach to providing nutritional support impacts neonatal morbidity and long-term neuro developmental outcomes. While more and better evidence is needed to help guide best practices, this gap should not prevent neonatologists from using the observations in this review to improve their current practice. There is evidence that changes in nutritional support can have a positive influence on growth. These include early administration of intravenous amino acids and lipids, minimal enteral nutrition, and supplemented formula and human milk. Simply recognizing the degree of growth failure by monitoring weight and focusing on the accruing deficit should encourage clinicians to increase nutritional support to enhance recovery growth. Continued research is needed to define the efficiency of early feeding, more rapid advancements in nutritional support, protein needs, the optimal composition of breast-milk supplements, the etiology of necrotizing enterocolitis, and perhaps most importantly, the health consequences of extrauterine growth restriction.
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WHAT IS EXTRAUTERINE GROWTH RESTRICTION AND HOW PREVALENT IS IT?
The term, extrauterine growth restriction, refers to the concept that prematurely born neonates develop a severe nutritional deficit during the first weeks after birth. Despite some catch-up growth during the second month of hospitalization, many neonates go home under-grown. Their nutritional deficit affects not only their weight, but their length and head circumference as well. 1 The American Academy of Pediatrics (AAP) has suggested that in order to attain optimal nutritional support of the preterm neonate, postnatal growth approximating that of a normal fetus of the same postconceptional age should be achieved. 2, 3 Nutrient intakes that meet the recommended dietary intakes take time to establish and are hard to maintain throughout hospital stays. 4 This is especially true for the critically ill preterm neonate. As a result, a nutrient deficit accrues. Recommended dietary intakes are based on what is needed for maintenance and growth, with no provision to replace the accrued deficit. 4 A recent study suggests that postnatal malnutrition and growth restriction are inevitable, if we follow the current recommended dietary intakes. 4 Daily dietary intakes in preterm infants admitted to neonatal intensive-care units showed cumulative energy and protein deficits that were more than 300 kcal/kg and 12 g of protein/kg after just 1 week following birth. This deficit was greatest for neonates <30 weeks' estimated gestational age and continued to accumulate over the first month after birth. However, even neonates, who were Z30 weeks and relatively healthy, developed significant nutritional deficits before discharge. Stepwise regression analysis indicated that variation in dietary intake accounted for 45% of the variation in changes in growth.
Failure to see daily weight gain and failure to thrive are late manifestations of malnutrition. Growth measurements (weight, length, and head circumference) are macroscopic measures of nutritional status. In addition, weight gain that is only fat or water gain is not sufficient and rapid weight gain that is mainly fat may increase the risk for health problems later in life. [5] [6] [7] Energy deficiency, as well as micronutrient deficiency, can alter growth at cellular and systemic levels before macroscopic measures are altered. In the brain, energy is needed for cell division and growth (e.g., neuronal growth), transport via the radial glial cells, and myelination. Malnourished neonates often experience immune deficiencies that reflect poor protein stores, exacerbating an already immature immune system. In addition, nutrition may be therapeutic (reparative) for premature neonates by allowing more rapid adaptation to the extrauterine environment. To prevent growth failure and extrauterine growth restriction, we need to detect nutrient deficiencies early and act to correct them.
MAGNITUDE OF THE CURRENT PROBLEM AS DEFINED BY GROWTH RESTRICTION
Ehrenkranz et al. 8 reported that at hospital discharge, most infants born between 24 and 29 weeks' of gestation had not achieved the median birth weight of the reference fetus at the same postmenstrual age. This study graphically demonstrates how far neonates fall behind by plotting body weight versus postmenstrual age (Figure 1 ). When we evaluated extrauterine weight gain in premature neonates and compared it to our estimates of fetal growth, we found large differences in observed compared to expected growth ( Figure 2) . 1 In addition, the incidence of failureto-thrive (weight <5th percentile for age/sex) in extremely low birth-weight (weighing 400 to1000 g) neonates in the Neonatal Research Network cohort is more than 30% at 18 months' corrected age. The large number of growth-retarded neonates demands that we reassess the targets and indicators we set and use for adequate nutrition in neonatal intensive-care units and following discharge.
While low birth weight and immature gestational age are the most important nutritional factors influencing growth, there are several other factors (gender, need for assisted ventilation, necrotizing enterocolitis, and exposure to postnatal steroids) that are associated with extrauterine growth restriction. As described by Ehrenkranz et al., 8 premature neonates who are critically ill are more likely to have poor growth than less ill premature neonates. Sick neonates are fed less often, have increased metabolic demands, and their nutritional needs are rarely met, all of which result in malnutrition and poor growth. Exposure to steroids in the postnatal period also retards growth. 10, 11 Steroids are potent catabolic agents that alter organ and somatic growth. [12] [13] [14] Both hypertension and glucose intolerance are common complications of steroid administration and can accentuate problems with achieving adequate nutritional support. 10, 11 Two randomized control trials evaluating the efficacy of dexamethasone in the prevention of chronic lung disease have identified growth failure during steroid treatment as an adverse side effect. 10, 11 In the most recent study, dexamethasone-treated infants had lower weights and smaller head circumferences at 36 weeks' postmenstrual age than infants who were not treated with dexamethasone. 10 These data suggest that the adverse effects associated with the early use of steroids (during the first week after birth) persist at least until near-term adjusted age and may have life-long consequences.
WHAT ARE THE LONG-TERM CONSEQUENCES OF POOR GROWTH?
The most easily measured consequence of inadequate nutrition is poor growth in weight, length, and head circumference. In early life, poor growth may reset the potential for later growth. [15] [16] [17] [18] [19] There is growing evidence that growth is but one measure of adequate nutrient delivery. Nutrients are also important in priming the gastrointestinal system, brain, and immune system during critical periods of development through cell signaling. Calories and specific nutrients can be viewed as potent chemical reactors that can enhance utilization of other nutrients. In addition to the early developmental effects of nutrition, early nutrition or the failure thereof may program neonates for later morbidity.
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Nutrition in the NICU periods of nutritional ''exposures'' prenatally and during the postnatal period appear to influence an individual's disease risks throughout life. 17,22 -24 For example, there is an association between being born small-for-gestational-age and an increased risk of cardiovascular disease and type I diabetes later in life. 5, 25 In addition, birth weight and postnatal growth influence cognitive development and intelligence quotient. [26] [27] [28] Postnatal growth lag is associated with neurological and sensory handicaps and poor school performance. Hack et al. 29, 30 showed that subnormal head size at 8 months of age was predictive of poorer verbal and performance IQ scores at 8 years of age; lower scores for receptive language, speech, reading, mathematics, and spelling; and a higher incidence of hyperactivity. 29, 30 Population-based studies evaluating the effects of poor fetal growth support these observations. [26] [27] [28] 31, 32 
WHAT PROBLEMS PREVENT US FROM FEEDING PRE-MATURE NEONATES?
An important obstacle to initiation and advancing of enteral nutrition is fear of bowel injury and necrotizing enterocolitis. [33] [34] [35] Necrotizing enterocolitis is associated with significant morbidity and mortality. Despite years of investigation, the etiology remains unclear, and accepted prevention and treatment strategies are lacking. 36 Factors associated with bowel injury include feedings, prenatal/perinatal ischemia from placental insufficiency, 37 a prenatal history of maternal antibiotics, 38 exposure to a combination of indomethacin and steroids during the first week following birth, 10 and vaginal delivery. 39 The late onset (beyond 1 week of age) suggests that the etiological mechanisms involved in causing necrotizing enterocolitis have more to do with postnatal gut development and colonization than with prenatal events. 37 There is also evidence that certain factors in feedings may play a role in the prevention of necrotizing enterocolitis. For example, breast-milk feeding appears to decrease the incidence and severity of necrotizing enterocolitis. 40 Breast milk has IgG, secretory IgA (sIgA), lactoferrin, gut growth peptides (e.g., IG F-1, TGFa, and EGF) and other protective substances that appear to promote growth of the intestine and strengthen its immunologic barrier. [40] [41] [42] Other problems that prevent us from feeding premature neonates include feeding intolerance, inadequate gastric emptying, apnea, or illness. Decisions about when to start feedings, how to progress, and when to stop feedings all impact the rate at which nutritional deficits accrue. Clark et al. 43 have reported significant site variation in center-specific performance, as measured by extrauterine weight gain of low-birth-weight neonates. The difference in average weight gain per day between low-and highweight-gain centers was more than 3 g/day and these early differences in weight gain translated to heavier discharge weights for survivors (2.0±0.4 kg vs 2.3±0.6 kg, low-vs high-weight-gain centers) despite similar lengths of hospital stay. Much of this variation appears directly related to feeding processes. Olsen et al. 44 showed that weight growth velocity of premature infants varied significantly among six neonatal intensive-care units. Interestingly, adjustment for case mix and medical factors explained little of this variability. Instead, the authors found that calorie and especially protein intake accounted for much of the intersite variability. The authors suggested that adding 1 g/kg/day protein to the mean intake could increase growth by 4.1 g/kg/day. 44 It is clear that medical and nutritional decisions impact growth. Thus, education regarding best health-care strategies that promote better nutrition can be expected to have significant impact on growth outcomes. However, changes in medical practice must include follow-up monitoring to gauge the impact of these changes on other health outcomes (e.g., the incidence of necrotizing enterocolitis).
HOW DO WE USE PARENTERAL ALIMENTATION TO PROMOTE GROWTH IN PREMATURE NEONATES?
Addressing the nutritional needs of critically ill neonates can be divided into three phases: parenteral, transitional, and enteral. The parenteral phase represents the earliest phase when enteral feedings are poorly tolerated. The transition to the enteral phase represents a time when enteral feedings are inadequate to support nutrition and parenteral support is required for supplementation. The enteral phase represents the period when enteral nutritional support can be used as the sole source of nutrition. While we have addressed primarily the parenteral and enteral phases of nutrition, the transition between these two phases is a critical time period. Careful attention to growth and nutrition during transition can reduce the accrued deficits. The use of parenteral alimentation to provide nutrition until enteral feedings are initiated is not a new concept; however, nutritional targets continue to change. As we care for smaller and more critically ill neonates, we are faced with more neonates with very immature gastrointestinal organs. Supporting the growth and development of these neonates until they can tolerate enteral nutrition is essential.
Glucose infusions should start immediately in critically ill premature neonates 45 and data show that these neonates are able to oxidize glucose infused at a rate of up to 8 mg/kg/min. 45 The role of insulin in promoting increased energy intake for faster growth remains controversial. During an infusion of glucose alone, pharmacological concentrations of insulin in extremely-low-birthweight infants produced no net protein anabolic effect. 46 Furthermore, euglycemic hyperinsulinemia was accompanied by development of significant metabolic acidosis. 46 In prematurely born neonates, hormones produced in response to stress promote proteolysis and negative nitrogen balance. Protein loss and on going need for protein can make it hard to catch up. The accretion rate for protein, in utero, is 3.5 to 4 g/kg/day. [47] [48] [49] [50] [51] The minimum amount of protein support needed to prevent net loss of protein is 1 to 1.5 g/kg/day and at least 30 kcal/kg/day. 51 Nutrition in the NICU Clark et al.
While most neonatologists initiate nutritional support of amino acids at 0.5 g/kg/day and advance slowly by 0.5 g/kg every few days, this approach may be too conservative. 50, 51 Many premature neonates can tolerate up to 3 g/kg/day in the first days after birth without laboratory evidence of toxicity. 51 The problems with increased blood urea nitrogen and ammonia reported in older studies have largely disappeared with the advent of better amino-acid solutions and premature formulas. 48, 51 In addition, early use of amino acids may improve protein synthesis glucose tolerance and reduce the occurrence of nonoliguric hyperkalemia. 47, 48, 51 Lipid emulsions are also an essential element of parenteral nutritional support. To prevent essential fatty acid deficiency, 0.5 g/ kg/day of lipids are needed. Most authors recommend starting early and advancing to 3 g/kg/day. [52] [53] [54] There is increasing evidence that this approach is safe and is not associated with an increased risk for lung injury or kernicterus. 52, 53 Toxicities of prolonged exposure to hyperalimentation include liver damage, sepsis, and metabolic bone disease. 50,51,55 -57 Both hyperalimentation fluids and intralipids can serve as culture media for bacteria and fungus. 58 In a case-control study among 882 infants, infants with coagulase-negative Staphylococcus bacteremia were 5.8 times as likely as controls to have received intravenous lipid emulsion before the onset of bacteremia. In another study, 56% of all of the cases of nosocomial bacteremia could be attributed to lipid administration. 59 In addition, heparin may elicit superantigen (toxic shock) from Candida albicans and increase the virulence of Candida. 60 Since hyperalimentation fluids and intralipids are critical components of nutrition in premature infants, they remain an essential part of early management. Clinicians must balance the risk of infection versus the benefit of enhanced caloric intake when deciding how early to curtail the use of parenteral nutrition. Malnutrition also increases the risk of opportunistic infections.
Recent data show that lipid peroxidation may be another unrecognized source of significant toxicity. Intravenous lipids form peroxides when exposed to light. 52,61 -65 The degree of peroxidation is directly related to the degree of light exposure. Premature neonates who are receiving lipids and phototherapy can be exposed to significant amounts of lipid peroxides, if the lipids are not protected from light. The limited antioxidant capacity of critically premature neonates may make them particularly vulnerable to the toxicity of lipid peroxides.
While there are no defined indices or laboratory values that can be monitored to identify early signs of injury, changes in liver enzymes and bilirubin should alert the clinician that injury has occurred and promote a reassessment of nutritional support. Serum phosphorous, calcium, and alkaline phosphatase can be used to monitor for signs of metabolic bone disease. There is no clear method for monitoring lipid tolerance.
HOW DO WE USE ENTERAL FEEDINGS TO PROMOTE GROWTH IN PREMATURE NEONATES?
Human milk is the physiologic norm for nutrition of full-term and near-term infants. [66] [67] [68] The nutritional, immunologic, antiinfective, and developmental properties of human milk have been shown to be highly beneficial. [69] [70] [71] [72] Most of these benefits extend to prematurely born neonates, despite certain nutritional limitations of human milk for low-birth-weight infants.
19,73-77 Specific benefits of breast-milk feedings include reduced rates of necrotizing enterocolitis and acquired infections both in the hospital and after discharge. [69] [70] [71] The use of breast milk also reduces mortality and morbidity and can be attributed to decreased lengths of hospital stays and reduced health-care cost. 78 In addition, clinical trials show that interventions that promote breast-feeding increased the duration and degree (exclusivity) of breast-feeding and decreased the risk of gastrointestinal tract infection and atopic eczema in the first year after birth. 70, 78 Based upon the compelling evidence showing the health, nutritional, immunologic, developmental, psychological, social, economic, and environmental benefits of breast-feeding, the AAP recommends breast-feeding exclusively for approximately the first 6 months after birth and its continued use through at least the first year in neonates born at or near term gestation. 67 Despite the advantages of breast milk, its use is low in neonatal intensive-care units. 40, 79, 80 To be successful, the mother must believe that breast milk is best for her neonate. Even mothers who previously were not planning to breast-feed will strongly consider initiating breast pumping to help their preterm infants.
Anticipatory guidance (during pre-and postnatal visits) of mothers who have chosen to express breast milk is essential. Mothers should be supported and encouraged in maintaining milk supply and in breast-feeding. Staff members should not suggest that it is easier to give the infant a bottle. [81] [82] [83] [84] Developing strategies that identify which neonates are ready to breast-feed is also helpful. There is a considerable variation between infants in the extent of mouthing and the age at which infants can successfully breast-feed. [82] [83] [84] Age of an infant does not predict oral behavior. Electromyographic data can provide evidence of early sucking competence in preterm infants during breast-feeding and allow for earlier successful breast-feeding. [82] [83] [84] Increasing the amount and duration that breast milk is used in nourishing premature neonates is an important clinical goal.
BREAST-MILK FORTIFICATION
Specialized, multinutrient, powdered mixtures (fortifiers), complete liquid formulas designed to be mixed with human milk, complete powdered formulas to be mixed with human milk, and alternating feedings of human milk and preterm formula have all been used to augment the nutrient supply for human milk-fed premature infants. Fortified human milk provides premature infants adequate Clark et al. Nutrition in the NICU nutritional support when fed at approximately 180 ml/kg/ day. 40, 73, 74, 85 However, we have insufficient data to determine the precise quantity of nutrients that should be added as supplements and we need additional studies on nutrient interactions. 40, 73, 74, 85 Although there is evidence that growing premature neonates need large quantities of calcium, the type of exogenous calcium used in some human milk fortifiers may decrease fat absorption. Other supplemental elements in fortifiers may inactivate or decrease the intrinsic host-defense properties of human milk. Encouraging skinto-skin contact and nipple feeding is also important in that they promote maternal-infant bonding and alter the quality and quantity of maternal milk production. 40, 73, 74, 85 A recent clinical trial evaluated the growth and nutritional status of preterm infants receiving preterm human milk supplemented with a newly formulated, powdered, human-milk fortifier (study fortifier) or a powdered, commercial, human-milk fortifier. 86 Infants fed human milk supplemented with the new fortifier consistently grew more rapidly. The weight-gain difference was 2.6 g/kg/day. Likewise, the length-gain difference was 0.14 cm/ week. These results suggest improving the quality of human-milk fortifier can enhance the growth of preterm infants and emphasize the need for research that defines the protein, fat, and carbohydrate needs of premature neonates.
HOW SHOULD WE ADVANCE FEEDINGS?
Recent reports from the Cochrane Collaboration [87] [88] [89] review the trials evaluating minimal enteral feeding (or trophic feedings) compared to no feeding, early versus late feedings, and rapid versus slow rate of advancement of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low-birthweight infants. The data suggest that early minimal enteral feedings and more rapid advancement improve growth. However, all of the reviews conclude that there is inadequate data on safety and what constituted best practice and suggest that larger clinical trials are needed to define optimal care.
NEED FOR SUPPLEMENTATION AFTER THE PREMATURE NEONATE GOES HOME
As discharge planning from the neonatal intensive-care unit is initiated, it is important to recognize that many of the neonates are growth-retarded and have large cumulative nutritional deficiencies. 1, 8, 44 Carver et al. 90 studied the effect of feeding premature neonates fortified formula after hospital discharge. Compared to infants fed 20 kcal/fl oz term-infant formula, infants fed the fortified formula (22 kcal/fl oz with increased protein, vitamins, and minerals) weighed more at 1 and 2 months and were longer at 3 months of age. There were significant interactions between feeding and birth-weight group. Neonates who weighed less than 1250 g at birth and who were fed enriched formula weighed more and were longer at 6 months and had better head growth than neonates fed the standard formula. The changes seen in neonates who had birth weights greater than 1250 g were less dramatic. Infants who were fed the enriched formula consumed less formula and had higher protein intakes. Interestingly, energy intakes were not different. The authors concluded that growth was improved in preterm infants fed a nutrient-enriched postdischarge formula after hospital discharge to 12 months.
In a similar study of preterm neonates, Lucas et al. 77 tested the hypothesis ''that nutritional intervention in the first nine months post-term would reverse postdischarge growth deficits and improve neurodevelopment without adverse safety outcomes.'' At 9 months, compared with the standard term formula group, those fed enriched formula were heavier and longer. There was no effect on head circumference or in developmental scores at 9 or 18 months. While not significantly different, neonates fed the enriched formula did have a 2.8-point advantage in Bayley motor scale score. At 6 weeks' post-term, preterm neonates who were exclusively breast-fed were 513 g lighter and 1.6 cm shorter than the enriched-formula group, and they remained smaller up to 9 months' post-term. The authors concluded that improving postdischarge nutrition in the first 9 months may ''reset'' subsequent growth for body length, at least until 18 months. The use of the enriched formula was not associated with adverse safety outcomes. This study also raised the possibility that breast-fed preterm infants may require nutritional supplementation after hospital discharge.
SUMMARY
Extrauterine growth restriction is a major clinical problem for prematurely born neonates, especially critically ill preterm neonates, and malnutrition in the neonatal intensive-care unit remains common. There are numerous perceived risks to initiation of adequate nutritional support. How many of these factors pose a real risk to health outcomes is less clear. Current nutritional support does not prevent extrauterine growth restriction and the consequences of malnutrition are both acute and delayed. Our clinical approach to providing nutritional support impacts neonatal morbidity and long-term neurodevelopmental outcomes. While more and better evidence is needed to help guide best practices, this gap should not prevent neonatologists from using the observations in this review to improve their current practice. There is credible evidence that small safe changes in current practice can have a positive influence on growth. 44, 51, 90 These include early administration of intravenous amino acids and lipids, minimal enteral nutrition, and supplemented formula and human milk. Simply recognizing the degree of growth failure by monitoring weight and focusing on the accruing deficit should encourage clinicians to increase nutritional support to enhance recovery growth. Continued research is needed to define the efficacy of early feeding, more rapid advancements in nutritional support, protein needs, the optimal composition of breast-milk supplements, the etiology of necrotizing enterocolitis, and perhaps most importantly, the health consequences of extrauterine growth restriction.
